Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

44°
- Benton, AR (72018)
  Today
  
  Cloudy. A stray thunderstorm is possible. High 53F. Winds light and variable..
  
  Tonight
  
  A few passing clouds. Low 32F. Winds light and variable.
  
  Updated: January 21, 2026 @ 12:13 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Reviva Pharmaceuticals Holdings, Inc. - Common Stock (NQ:RVPH)

0.3217 -0.0183 (-5.38%)

Streaming Delayed Price Updated: 1:40 PM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Reviva Pharmaceuticals Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024 ↗

August 14, 2024

RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH

May 16, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Regulatory Compliance

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH

May 16, 2024

WHY: NEW YORK, NY - (NewMediaWire) - May 16, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Reviva...

Via TheNewswire.com

Topics Regulatory Compliance

RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q1 2024 ↗

May 14, 2024

RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH

May 14, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Expert Ratings for Reviva Pharmaceuticals ↗

June 26, 2023

Via Benzinga

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH

May 13, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Regulatory Compliance

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH

May 13, 2024

WHY: NEW YORK, NY - (NewMediaWire) - May 13, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Reviva...

Via TheNewswire.com

Topics Regulatory Compliance

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 09, 2024

Via Benzinga

RVPH LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH

April 25, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm

April 25, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023 ↗

April 15, 2024

RVPH stock results show that Reviva Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs ↗

January 23, 2024

These three companies are developing treatments for brain diseases that have a great deal of potential, making them top neuroscience stocks.

Via InvestorPlace

Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

January 10, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

Life Science Investor Forum: Presentations Now Available for Online Viewing

December 15, 2023

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Investor Forum Agenda Announced for December 14th, 2023

December 12, 2023

From Virtual Investor Conferences

Via GlobeNewswire

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

December 11, 2023

From Virtual Investor Conferences

Via GlobeNewswire

Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock ↗

October 30, 2023

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 30, 2023

Via Benzinga

Could This Be A Breakthrough in Mental Health? Reviva's Schizophrenia Drug Shows Promising Results In Key Trial ↗

October 30, 2023

Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) announced the topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine signaling modulator in

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 27, 2023

Via Benzinga

Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

September 29, 2023

Via ACCESSWIRE

Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

September 22, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023 ↗

September 20, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 17, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 17, 2023

It's time for another dive into the biggest pre-market stock movers this morning as we check out the latest news on Thursday!

Via InvestorPlace

RedChip Launches 'Small Stocks, Big Money' Podcast

August 02, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Reviva Pharmaceuticals Holdings, Inc. - Common Stock (NQ:RVPH)

All News about Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Sections

Services

Follow Us